Logo of National Eczema Association mobile menu icon
Icon link to National Eczema's Instagram feed. Icon link to National Eczema's YouTube channel. Icon link to National Eczema's Facebook page. Icon link to National Eczema's Twitter feed. Eczema-wise logo link to National Eczema's inspire.com page. Search Icon to search the site

Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Clinical Trials

A clinical trial is a research study in human volunteers used to determine whether new drugs or treatments are safe and effective. Clinical testing is preceded by extensive laboratory research, and is normally done in five phases. Participants can help themselves and others by contributing to medical research.

The following information is presented as a service to those who might be interested in participating in clinical research trials studying atopic dermatitis/eczema. Please click on the title of the research study for more information. Please feel free to contact the NEA office for more information.

Clinical Trial Postings

Postdate: May 26, 2017

A Randomized, Double -Blind, Placebo-Controlled, Sequential, Multiple-Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Preliminary Efficacy Of ASN002

Postdate: April 21, 2017

A Randomised, Double-blind, Vehicle-Controlled, Phase IIb Study to Assess the Efficacy of Topically Applied DS107

Postdate: March 13, 2017

Tradipitant in treatment-resistant pruritis associated with AD

Postdate: March 13, 2017

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis

Postdate: March 13, 2017

Phase 2b Study for Patients with Moderate to Severe Atopic Dermatitis

Postdate: March 3, 2017

Phase 2 Study of RVT-501 in Adult and Adolescent Subjects with Atopic Dermatitis

Postdate: December 22, 2016

Clinical Study to Evaluation the Effectiveness of a New Oral Medication for Atopic Dermatitis

Postdate: November 16, 2016

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of XXXXX to the Marketed Product XXXXX Cream, XXXXX in the Treatment of Mild to Moderate Atopic Dermatitis

Postdate: September 1, 2016

A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Bioequivalence of a Generic XXXX and Reference Listed XXXX and Compare Both Active Treatments to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis

Postdate: June 22, 2016
Atopic Dermatitis (Eczema) Research Study

Postdate: May 6, 2016
A Randomized, Double-Blind, Vehicle-Controlled Ascending Multiple Dose and Clinical Proof–of-Concept Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VTP-38543 in Adult Patients with Mild to Moderate Atopic Dermatitis

Postdate: April 7, 2016
Protobol 14V-MC-JAHG(b) A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis


National Eczema Association Clinical Trials Policy

The National Eczema Association (NEA) is committed to improving patients’ quality of life through research, education, and support. NEA does not provide medical advice to patients but provides information to help them better understand their health, diagnosed conditions and the current range of approaches related to eczema treatment, prevention and supportive care. NEA urges patients to consult with a qualified physician for diagnosis and treatment.

As part of the fulfillment of its mission, NEA provides information to its constituents regarding clinical research trial availability and participation. NEA does not recruit patients for clinical trials and NEA does not conduct clinical trials. Below is a notice for a research study that we thought might be of interest to you. NEA is providing this information as a service. NEA does not endorse the study, which is being conducted at locations and under protocols that are not monitored or reviewed by NEA. Accordingly, NEA cannot be held responsible for anything that may occur in connection with the study. NEA may be reimbursed by the sponsor of the study for costs incurred in connection with notifying NEA constituents of the availability of the study. Should you have any questions regarding the study, please contact the study sponsor.

NEA respects your privacy and does not release your private information to any outside individuals, companies or organizations. Please see complete NEA Clinical Trials Policy here.

Other Clinical Trials

Clinicaltrials.gov is a registry of federally or privately supported clinical trials conducted in the United States and around the world.